Paraneoplastic neurological syndromes

per Leypoldt, F, Wandinger, K-P
Publicat 2014

Successful immunosuppressive treatment and long‐term follow‐up of anti‐Ri‐associated paraneoplastic myelitis

per Leypoldt, F, Eichhorn, P, Saager, C, Münchau, A, Lewerenz, J
Publicat 2006

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature

per Jarius, S., Ruprecht, K., Stellmann, J. P., Huss, A., Ayzenberg, I., Willing, A., Trebst, C., Pawlitzki, M., Abdelhak, A., Grüter, T., Leypoldt, F., Haas, J., Kleiter, I., Tumani, H., Fechner, K., Reindl, M., Paul, F., Wildemann, B.
Publicat a J Neuroinflammation (2018)

S1 guidelines “lumbar puncture and cerebrospinal fluid analysis” (abridged and translated version)

per Tumani, H., Petereit, H. F., Gerritzen, A., Gross, C. C., Huss, A., Isenmann, S., Jesse, S., Khalil, M., Lewczuk, P., Lewerenz, J., Leypoldt, F., Melzer, N., Meuth, S. G., Otto, M., Ruprecht, K., Sindern, E., Spreer, A., Stangel, M., Strik, H., Uhr, M., Vogelgsang, J., Wandinger, K.-P., Weber, T., Wick, M., Wildemann, B., Wiltfang, J., Woitalla, D., Zerr, I., Zimmermann, T.
Publicat a Neurol Res Pract (2020)